| Pathogenicity |
Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility. |
Kresken M, Klare I, Wichelhaus TA, Wohlfarth E, Layer-Nicolaou F, Neumann B, Werner G |
J Glob Antimicrob Resist |
10.1016/j.jgar.2021.12.016 |
2021 |
* |
| Pathogenicity |
Detection of Vancomycin-Resistant Enterococcus faecium Endocarditis After Clearance of Vancomycin-Sensitive Enterococcus faecium Bacteremia. |
McEllistrem MC, Nordstrom HR, Lucas A, Decker BK, Van Tyne D |
Microb Drug Resist |
10.1089/mdr.2021.0233 |
2021 |
* |
| Genetics |
Genetic description of VanD phenotype vanA genotype in vancomycin-resistant Enterococcus faecium isolates from a Bone Marrow Transplantation Unit. |
Marchi AP, Neto LVP, Cortes MF, de Castro Lima VAC, Martins RCR, Franco LAM, Rossi F, Rocha V, Levin AS, Costa SF |
Braz J Microbiol |
10.1007/s42770-021-00634-9 |
2021 |
* |
| Pathogenicity |
In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci. |
Tong J, Jiang Y, Xu H, Jin X, Zhang L, Ying S, Yu W, Qiu Y |
Drug Des Devel Ther |
10.2147/DDDT.S315061 |
2021 |
* |
| Phylogeny |
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan. |
Fujiya Y, Harada T, Sugawara Y, Akeda Y, Yasuda M, Masumi A, Hayashi J, Tanimura N, Tsujimoto Y, Shibata W, Yamaguchi T, Kawahara R, Nishi I, Hamada S, Tomono K, Kakeya H |
Sci Rep |
10.1038/s41598-021-94213-5 |
2021 |
* |
| Biotechnology |
Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. |
Pandey R, Mishra SK, Shrestha A |
Infect Drug Resist |
10.2147/IDR.S306688 |
2021 |
* |
| Metabolism |
Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium. |
Gargvanshi S, Vemula H, Gutheil WG |
J Bacteriol |
10.1128/JB.00230-21 |
2021 |
* |
| Metabolism |
ddcP, pstB, and excess D-lactate impact synergism between vancomycin and chlorhexidine against Enterococcus faecium 1,231,410. |
Bhardwaj P, Islam MZ, Kim C, Nguyen UT, Palmer KL |
PLoS One |
10.1371/journal.pone.0249631 |
2021 |
* |
| Pathogenicity |
N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium. |
Szucs Z, Bereczki I, Roth E, Milankovits M, Ostorhazi E, Batta G, Nagy L, Dombradi Z, Borbas A, Herczegh P |
J Antibiot (Tokyo) |
10.1038/s41429-020-0313-6 |
2020 |
* |
| Phenotype |
Impact of vanA-Positive Enterococcus faecium Exhibiting Diverse Susceptibility Phenotypes to Glycopeptides on 30-Day Mortality of Patients with a Bloodstream Infection. |
Kim D, Yoon EJ, Hong JS, Lee H, Shin KS, Shin JH, Kim YR, Kim HS, Kim YA, Uh Y, Shin JH, Park YS, Jeong SH |
Antimicrob Agents Chemother |
10.1128/AAC.02180-19 |
2020 |
* |
| Pathogenicity |
Quantifying Human Health Risks from Virginiamycin Use in Food Animals in China. |
Cox LA Jr, Popken DA, Sun J, Liao XP, Fang LX |
Risk Anal |
10.1111/risa.13466 |
2020 |
* |
| Genetics |
First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a vanA Gene Cluster-Carrying Linear Plasmid. |
Hashimoto Y, Kita I, Suzuki M, Hirakawa H, Ohtaki H, Tomita H |
mSphere |
10.1128/mSphere.00102-20 |
2020 |
* |
| Pathogenicity |
Antibiogram of Urinary Enterococcus Isolates from a Tertiary Care Hospital. |
Bhat NR, Shivashankar SBK, Dhanashree B |
Infect Disord Drug Targets |
10.2174/1871526520666200403140618 |
2021 |
* |
| Pathogenicity |
Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey. |
Asgin N, Otlu B |
Infect Drug Resist |
10.2147/IDR.S191881 |
2020 |
* |
| Pathogenicity |
Expression of VanA-type vancomycin resistance in a clinical isolate of Enterococcus faecium showing insertion of IS19 in the vanS gene. |
Monteiro da Silva BN, Faria AR, Souza SDSR, Colodette SS, Morais JM, Teixeira LM, Merquior VLC |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2020.105897 |
2020 |
* |
| Pathogenicity |
Novel Multidrug-Resistant Enterococcal Mobile Linear Plasmid pELF1 Encoding vanA and vanM Gene Clusters From a Japanese Vancomycin-Resistant Enterococci Isolate. |
Hashimoto Y, Taniguchi M, Uesaka K, Nomura T, Hirakawa H, Tanimoto K, Tamai K, Ruan G, Zheng B, Tomita H |
Front Microbiol |
10.3389/fmicb.2019.02568 |
2019 |
* |
| Genetics |
Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary. |
Franyo D, Kocsi B, Bukta EE, Szabo J, Dombradi Z |
Folia Microbiol (Praha) |
10.1007/s12223-019-00751-x |
2019 |
* |
| Pathogenicity |
TiCaPCON-Supported Pt- and Fe-Based Nanoparticles and Related Antibacterial Activity. |
Ponomarev VA, Sheveyko AN, Permyakova ES, Lee J, Voevodin AA, Berman D, Manakhov AM, Michlicek M, Slukin PV, Firstova VV, Ignatov SG, Chepkasov IV, Popov ZI, Shtansky DV |
ACS Appl Mater Interfaces |
10.1021/acsami.9b09649 |
2019 |
* |
| Pathogenicity |
VanA-type vancomycin-resistant Enterococcus faecium ST1336 isolated from mussels in an anthropogenically impacted ecosystem. |
Sacramento AG, Fernandes MR, Sellera FP, Dolabella SS, Zanella RC, Cerdeira L, Lincopan N |
Mar Pollut Bull |
10.1016/j.marpolbul.2019.04.014 |
2019 |
* |
| Pathogenicity |
Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda. |
Kateete DP, Edolu M, Kigozi E, Kisukye J, Baluku H, Mwiine FN, Najjuka CF |
BMC Infect Dis |
10.1186/s12879-019-4136-7 |
2019 |
* |
| Pathogenicity |
In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci. |
Wu T, Meyer K, Harrington AT, Danziger LH, Wenzler E |
J Antimicrob Chemother |
10.1093/jac/dkz010 |
2019 |
* |
| Pathogenicity |
Phenotypic and genetic characteristics of vancomycin-resistant Enterococcus faecium. |
Yang J, Yuan Y, Tang M, Liu L, Yang K, Liu J |
Microb Pathog |
10.1016/j.micpath.2018.12.046 |
2018 |
* |
| Genetics |
Draft Genome Sequence of Enterococcus faecium CL-6729, a Clinical Isolate Showing Constitutive Vancomycin Resistance. |
Monteiro da Silva BN, Faria AR, de Souza SDSR, Planet PJ, Merquior VLC, Teixeira LM |
Microbiol Resour Announc |
10.1128/MRA.00888-18 |
2018 |
* |
| Genetics |
Emergence of unusual vanA/vanB2 genotype in a highly mutated vanB2-vancomycin-resistant hospital-associated E. faecium background in Vietnam. |
Santona A, Taviani E, Hoang HM, Fiamma M, Deligios M, Ngo TVQ, Van Le A, Cappuccinelli P, Rubino S, Paglietti B |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2018.07.006 |
2018 |
* |
| Phylogeny |
Characterization of Clinical Vancomycin-Resistant Enterococcus faecium Isolated in Eastern Hungary. |
Franyo D, Kocsi B, Lesinszki V, Paszti J, Kozak A, Bukta EE, Szabo J, Dombradi Z |
Microb Drug Resist |
10.1089/mdr.2018.0074 |
2018 |
* |
| Pathogenicity |
Vancomycin resistant Enterococci: A brief review. |
Raza T, Ullah SR, Mehmood K, Andleeb S |
J Pak Med Assoc |
8691 |
2018 |
* |
| Pathogenicity |
Dissemination of VanA-Type Enterococcus faecium Isolates in Hungary. |
Melegh S, Nyul A, Kovacs K, Kovacs T, Ghidan A, Dombradi Z, Szabo J, Berta B, Lesinszki V, Paszti J, Toth A, Mestyan G |
Microb Drug Resist |
10.1089/mdr.2017.0296 |
2018 |
* |
| Pathogenicity |
Analysis of the world epidemiological situation among vancomycin-resistant Enterococcus faecium infections and the current situation in Poland |
Talaga-Cwiertnia K, Bulanda M |
Przegl Epidemiol |
|
2018 |
* |
| Pathogenicity |
Presence of the esp gene in Enterococcus faecium derived from oropharyngeal microbiota of haematology patients. |
Jovanovic M, Tosic T, Jovanovic S, Stosovic R, Stevanovic G, Velebit B, Zervos MJ |
Arch Oral Biol |
10.1016/j.archoralbio.2018.01.008 |
2018 |
* |
| Pathogenicity |
Immunological responses against vancomycin-resistant Enterococcus faecium and Enterococcus faecalis by mice. |
Cho YS, Lee MH, Kim JM, Lee HS, Yoo HS, Park YH, Ryu PD |
J Immunoassay Immunochem |
10.1080/15321819.2017.1407943 |
2018 |
* |
| Genetics |
Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan. |
Chen CH, Lin LC, Chang YJ, Chang CY |
Medicine (Baltimore) |
10.1097/MD.0000000000009000 |
2017 |
* |
| Enzymology |
High rates of colonisation by ampicillin-resistant enterococci in residents of long-term care facilities in Porto, Portugal. |
Freitas AR, Novais C, Duarte B, Pereira AP, Coque TM, Peixe L |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2017.11.007 |
2017 |
* |
| Phylogeny |
Streptomyces swartbergensis sp. nov., a novel tyrosinase and antibiotic producing actinobacterium. |
le Roes-Hill M, Prins A, Meyers PR |
Antonie Van Leeuwenhoek |
10.1007/s10482-017-0979-3 |
2017 |
* |
| Enzymology |
Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Infection. |
Belley A, Lalonde-Seguin D, Arhin FF, Moeck G |
Antimicrob Agents Chemother |
10.1128/AAC.01265-17 |
2017 |
* |
| Enzymology |
First description in Europe of the emergence of Enterococcus faecium ST117 carrying both vanA and vanB genes, isolated in Greece. |
Papagiannitsis CC, Malli E, Florou Z, Medvecky M, Sarrou S, Hrabak J, Petinaki E |
J Glob Antimicrob Resist |
10.1016/j.jgar.2017.07.010 |
2017 |
* |
| Pathogenicity |
Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014). |
Duncan LR, Sader HS, Smart JI, Flamm RK, Mendes RE |
J Glob Antimicrob Resist |
10.1016/j.jgar.2017.03.018 |
2017 |
* |
| Enzymology |
First outbreak of colonization by linezolid- and glycopeptide-resistant Enterococcus faecium harbouring the cfr gene in a UK nephrology unit. |
Inkster T, Coia J, Meunier D, Doumith M, Martin K, Pike R, Imrie L, Kane H, Hay M, Wiuff C, Wilson J, Deighan C, Hopkins KL, Woodford N, Hill R |
J Hosp Infect |
10.1016/j.jhin.2017.07.003 |
2017 |
* |
| Phylogeny |
Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran. |
Shokouhi S, Darazam IA, Javadi A, Rouhani M, Ghasemnejad M |
Infect Disord Drug Targets |
10.2174/1871526517666170210164649 |
2017 |
* |
| Enzymology |
A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies. |
Alatorre-Fernandez P, Mayoral-Teran C, Velazquez-Acosta C, Franco-Rodriguez C, Flores-Moreno K, Cevallos MA, Lopez-Vidal Y, Volkow-Fernandez P |
Am J Infect Control |
10.1016/j.ajic.2016.10.002 |
2016 |
* |
| Metabolism |
Incorporation of a Valine-Leucine-Lysine-Containing Substrate in the Bacterial Cell Wall. |
Hansenova Manaskova S, Bikker FJ, Nazmi K, van Zuidam R, Slotman JA, van Cappellen WA, Houtsmuller AB, Veerman EC, Kaman WE |
Bioconjug Chem |
10.1021/acs.bioconjchem.6b00381 |
2016 |
* |
| Phylogeny |
Diversity of plasmids and Tn1546-type transposons among VanA Enterococcus faecium in Poland. |
Wardal E, Kuch A, Gawryszewska I, Zabicka D, Hryniewicz W, Sadowy E |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-016-2804-8 |
2016 |
* |
| Pathogenicity |
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency. |
Mendes RE, Castanheira M, Farrell DJ, Flamm RK, Sader HS, Jones RN |
J Antimicrob Chemother |
10.1093/jac/dkw319 |
2016 |
* |
| Enzymology |
Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012). |
Freitas AR, Tedim AP, Francia MV, Jensen LB, Novais C, Peixe L, Sanchez-Valenzuela A, Sundsfjord A, Hegstad K, Werner G, Sadowy E, Hammerum AM, Garcia-Migura L, Willems RJ, Baquero F, Coque TM |
J Antimicrob Chemother |
10.1093/jac/dkw312 |
2016 |
* |
| Pathogenicity |
Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report. |
Jakovac S, Bojic EF, Ibrisimovic MA, Tutis B, Ostojic M, Hukic M |
Microb Drug Resist |
10.1089/mdr.2015.0355 |
2016 |
* |
| Metabolism |
Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner. |
van der Aart LT, Lemmens N, van Wamel WJ, van Wezel GP |
Antimicrob Agents Chemother |
10.1128/AAC.00276-16 |
2016 |
* |
| Pathogenicity |
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. |
Mendes RE, Flamm RK, Farrell DJ, Sader HS, Jones RN |
J Chemother |
10.1179/1973947815Y.0000000050 |
2016 |
* |
| Pathogenicity |
Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. |
Yang JX, Li T, Ning YZ, Shao DH, Liu J, Wang SQ, Liang GW |
Infect Genet Evol |
10.1016/j.meegid.2015.05.012 |
2015 |
* |
| Enzymology |
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method. |
Mendes RE, Farrell DJ, Sader HS, Streit JM, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2014.12.011 |
2014 |
* |
| Phylogeny |
Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital. |
Merlo TP, Dabul AN, Camargo IL |
Microb Drug Resist |
10.1089/mdr.2014.0077 |
2015 |
* |
| Proteome |
Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. |
Ramos S, Chafsey I, Silva N, Hebraud M, Santos H, Capelo-Martinez JL, Poeta P, Igrejas G |
J Proteomics |
10.1016/j.jprot.2014.10.012 |
2014 |
* |
| Pathogenicity |
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13). |
Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN |
J Antimicrob Chemother |
10.1093/jac/dku421 |
2014 |
* |
| Pathogenicity |
[In vitro antimicrobial susceptibility in Enterococcus faecalis and Enterococcus faecium isolated from hospitalized patients]. |
Medell M, Hart M, Batista ML |
Biomedica |
10.1590/S0120-41572014000500007 |
2014 |
* |
| Pathogenicity |
Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China. |
Kang M, Xie Y, He C, Chen ZX, Guo L, Yang Q, Liu JY, Du Y, Ou QS, Wang LL |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-013-2029-z |
2014 |
* |
| Metabolism |
Functional motions modulating VanA ligand binding unraveled by self-organizing maps. |
Bouvier G, Duclert-Savatier N, Desdouits N, Meziane-Cherif D, Blondel A, Courvalin P, Nilges M, Malliavin TE |
J Chem Inf Model |
10.1021/ci400354b |
2014 |
* |
| Phenotype |
Diversity of Tn1546 in vanA-positive Enterococcus faecium clinical isolates with VanA, VanB, and VanD phenotypes and susceptibility to vancomycin. |
Cha JO, Yoo JI, Kim HK, Kim HS, Yoo JS, Lee YS, Jung YH |
J Appl Microbiol |
10.1111/jam.12300 |
2013 |
* |
| Genetics |
Clinical and microbiological characteristics of vancomycin-resistant enterococci with the VanD phenotype and vanA genotype. |
Song JY, Cheong HJ, Seo YB, Kim IS, Heo JY, Noh JY, Choi WS, Kim WJ |
Jpn J Infect Dis |
10.7883/yoken.66.1 |
2013 |
* |
| Pathogenicity |
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci. |
Hope R, Chaudhry A, Adkin R, Livermore DM |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2012.10.016 |
2013 |
* |
| Enzymology |
Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina. |
Delpech G, Pourcel G, Schell C, De Luca M, Basualdo J, Bernstein J, Grenovero S, Sparo M |
Foodborne Pathog Dis |
10.1089/fpd.2012.1192 |
2012 |
* |
| Pathogenicity |
Polyclonal outbreak of vancomycin-resistant Enterococcus faecium in a pediatric oncology department. |
Iosifidis E, Karakoula K, Protonotariou E, Kaperoni M, Matapa E, Pournaras S, Koliouskas D, Sofianou D, Roilides E |
J Pediatr Hematol Oncol |
10.1097/MPH.0b013e318257a5d3 |
2012 |
* |
| Pathogenicity |
Vancomycin-resistant enterococci (VRE) isolates isolated in Rajavithi Hospital between 1999 and 2009. |
Thongkoom P, Kanjanahareutai S, Chantrakooptungool S, Rahule S |
J Med Assoc Thai |
|
2012 |
* |
| Pathogenicity |
Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. |
Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE |
Clin Infect Dis |
10.1093/cid/cir924 |
2012 |
* |
| Pathogenicity |
Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak. |
Zabicka D, Strzelecki J, Wozniak A, Strzelecki P, Sadowy E, Kuch A, Hryniewicz W |
Antonie Van Leeuwenhoek |
10.1007/s10482-011-9681-z |
2011 |
* |
| Pathogenicity |
[Frequency of vancomycin-resistant enterococci isolated from blood cultures from 2008 to 2010]. |
Mihajlovic Ukropina M, Jelesic Z, Gusman V, Milosavljevic B |
Med Pregl |
10.2298/mpns1110481m |
2011 |
* |
| Metabolism |
Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland. |
Kowalska-Krochmal B, Dworniczek E, Dolna I, Bania J, Walecka E, Seniuk A, Gosciniak G |
Adv Med Sci |
10.2478/v10039-011-0022-2 |
2011 |
* |
| Enzymology |
Changes in vancomycin-resistant Enterococcus faecium causing outbreaks in Brazil. |
Palazzo IC, Pitondo-Silva A, Levy CE, da Costa Darini AL |
J Hosp Infect |
10.1016/j.jhin.2011.04.016 |
2011 |
* |
| Enzymology |
Genetic organization and mode of action of a novel bacteriocin, bacteriocin 51: determinant of VanA-type vancomycin-resistant Enterococcus faecium. |
Yamashita H, Tomita H, Inoue T, Ike Y |
Antimicrob Agents Chemother |
10.1128/AAC.01274-10 |
2011 |
* |
| Pathogenicity |
Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. |
de Niederhausern S, Bondi M, Messi P, Iseppi R, Sabia C, Manicardi G, Anacarso I |
Curr Microbiol |
10.1007/s00284-011-9868-6 |
2011 |
* |
| Pathogenicity |
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia. |
Pfaller MA, Mendes RE, Sader HS, Jones RN |
J Antimicrob Chemother |
10.1093/jac/dkq335 |
2010 |
* |
| Pathogenicity |
Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. |
Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC |
J Clin Microbiol |
10.1128/JCM.01522-10 |
2010 |
* |
| Enzymology |
vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. |
Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M |
Antimicrob Agents Chemother |
10.1128/AAC.01710-09 |
2010 |
* |
| Pathogenicity |
Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages. |
Sletvold H, Johnsen PJ, Wikmark OG, Simonsen GS, Sundsfjord A, Nielsen KM |
J Antimicrob Chemother |
10.1093/jac/dkq219 |
2010 |
* |
| Phylogeny |
Characterization of vancomycin-resistant Enterococcus isolates from broilers in Selangor, Malaysia. |
Getachew YM, Hassan L, Zakaria Z, Saleha AA, Kamaruddin MI, Che Zalina MZ |
Trop Biomed |
|
2009 |
* |
| Pathogenicity |
Synthesis, crystal and antibacterial studies of diversely functionalized tetrahydropyridin-4-ol. |
Aridoss G, Amirthaganesan S, Jeong YT |
Bioorg Med Chem Lett |
10.1016/j.bmcl.2010.02.015 |
2010 |
* |
| Pathogenicity |
Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates. |
Raponi G, Ghezzi MC, Gherardi G, Lorino G, Dicuonzo G |
J Med Microbiol |
10.1099/jmm.0.016444-0 |
2010 |
* |
| Enzymology |
Characterisation of vancomycin-resistant enterococci from hospitalised patients at a tertiary centre over a seven-year period. |
Chang CM, Wang LR, Lee HC, Lee NY, Wu CJ, Ko WC |
J Hosp Infect |
10.1016/j.jhin.2009.10.025 |
2010 |
* |
| Phylogeny |
[First isolation and detection of multiple clones of vancomycin-resistant enterococci in the pediatric unit of Van Yuzuncu Yil University Turkey]. |
Guducuoglu H, Aktas E, Begendik Comert F, Aygul K, Ozlu N, Baykal S, Berktas M, Ceylan A |
Mikrobiyol Bul |
|
2009 |
* |
| Pathogenicity |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates. |
Arhin FF, Draghi DC, Pillar CM, Parr TR Jr, Moeck G, Sahm DF |
Antimicrob Agents Chemother |
10.1128/AAC.00952-09 |
2009 |
* |
| Enzymology |
vanA in Enterococcus faecium, Enterococcus faecalis, and Enterococcus casseliflavus detected in French cattle. |
Haenni M, Saras E, Chatre P, Meunier D, Martin S, Lepage G, Menard MF, Lebreton P, Rambaud T, Madec JY |
Foodborne Pathog Dis |
10.1089/fpd.2009.0303 |
2009 |
* |
| Pathogenicity |
[Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Ninos de Cordoba]. |
Reale AL, Depetri ML, Culasso C, Paviolo M, Cheguirian ML, Enrico MC, Ledesma EM, Vidal C, Glatstein E, Bertoni L |
Rev Argent Microbiol |
S0325-75412009000200006 |
2009 |
* |
| Enzymology |
High prevalence of ST-78 infection-associated vancomycin-resistant Enterococcus faecium from hospitals in Asuncion, Paraguay. |
Khan MA, Northwood JB, Loor RG, Tholen AT, Riera E, Falcon M, van Belkum A, van Westreenen M, Hays JP |
Clin Microbiol Infect |
10.1111/j.1469-0691.2009.02898.x |
2009 |
* |
| Phylogeny |
Streptomyces polyantibioticus sp. nov., isolated from the banks of a river. |
le Roes-Hill M, Meyers PR |
Int J Syst Evol Microbiol |
10.1099/ijs.0.006171-0 |
2009 |
* |
| Phylogeny |
[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]. |
Surcouf C, Fabre M, Enouf V, Cade S, Soler C, Mac Nab C, Samson T, Foissaud V |
Pathol Biol (Paris) |
10.1016/j.patbio.2009.04.004 |
2009 |
* |
| Pathogenicity |
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. |
McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T Jr, Moeck G |
J Antimicrob Chemother |
10.1093/jac/dkp126 |
2009 |
* |
| Phylogeny |
Classification and antimicrobial susceptibilities of enterococcus species isolated from apparently healthy food-producing animals in Japan. |
Kojima A, Morioka A, Kijima M, Ishihara K, Asai T, Fujisawa T, Tamura Y, Takahashi T |
Zoonoses Public Health |
10.1111/j.1863-2378.2008.01204.x |
2009 |
* |
| Enzymology |
A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. |
Gu L, Cao B, Liu Y, Guo P, Song S, Li R, Dai H, Wang C |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2008.08.018 |
2009 |
* |
| Pathogenicity |
Emergence and spread of vancomycin resistance among enterococci in Europe. |
Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N |
Euro Surveill |
|
2008 |
* |
| Pathogenicity |
Vancomycin resistance VanS/VanR two-component systems. |
Hong HJ, Hutchings MI, Buttner MJ |
Adv Exp Med Biol |
10.1007/978-0-387-78885-2_14 |
2008 |
* |
| Pathogenicity |
Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran. |
Emaneini M, Aligholi M, Aminshahi M |
Pol J Microbiol |
|
2008 |
* |
| Phylogeny |
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. |
Libisch B, Lepsanovic Z, Top J, Muzslay M, Konkoly-Thege M, Gacs M, Balogh B, Fuzi M, Willems RJ |
Scand J Infect Dis |
10.1080/00365540802165740 |
2008 |
* |
| Enzymology |
Molecular characterization of enterococci harboring genotype and phenotype incongruence related to glycopeptide resistance isolated in Brazilian hospitals. |
Henrique PM, Palazzo IC, Zanella RC, Darini AL |
Mem Inst Oswaldo Cruz |
10.1590/s0074-02762008000300014 |
2008 |
* |
| Enzymology |
Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. |
Khan MA, van der Wal M, Farrell DJ, Cossins L, van Belkum A, Alaidan A, Hays JP |
J Antimicrob Chemother |
10.1093/jac/dkn173 |
2008 |
* |
| Pathogenicity |
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative. |
Draghi DC, Benton BM, Krause KM, Thornsberry C, Pillar C, Sahm DF |
J Antimicrob Chemother |
10.1093/jac/dkn124 |
2008 |
* |
| Phylogeny |
Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005. |
Mlynarczyk G, Grzybowska W, Mlynarczyk A, Tyski S, Kawecki D, Luczak M, Chmura A, Rowinski W |
Transplant Proc |
10.1016/j.transproceed.2007.08.045 |
2007 |
* |
| Pathogenicity |
[Investigation of phenotypic and genotypic characteristics of vancomycin-resistant Enterococcus faecium isolates]. |
Aktas Z, Diyarbakirli P, Bal C, Gurler N, Keser M, Somer A, Salman N |
Mikrobiyol Bul |
|
2007 |
* |
| Pathogenicity |
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. |
Schmidt-Hieber M, Blau IW, Schwartz S, Uharek L, Weist K, Eckmanns T, Jonas D, Ruden H, Thiel E, Brandt C |
Int J Hematol |
10.1532/IJH97.E0632 |
2007 |
* |
| Pathogenicity |
The first molecular analysis of clinical isolates of VanA-type vancomycin-resistant Enterococcus faecium strains in Mainland China. |
Zheng B, Tomita H, Xiao YH, Ike Y |
Lett Appl Microbiol |
10.1111/j.1472-765X.2007.02191.x |
2007 |
* |
| Pathogenicity |
Molecular characterization of vancomycin-resistant enterococcus faecium isolates from mainland China. |
Zheng B, Tomita H, Xiao YH, Wang S, Li Y, Ike Y |
J Clin Microbiol |
10.1128/JCM.00457-07 |
2007 |
* |
| Pathogenicity |
Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. |
Garcia-Migura L, Liebana E, Jensen LB |
J Antimicrob Chemother |
10.1093/jac/dkm186 |
2007 |
* |
| Pathogenicity |
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. |
Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2006.12.022 |
2007 |
* |
| Phylogeny |
VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. |
Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, Guaglianone E, Sundsfjord A, Pruzzo C, Donelli G, Facinelli B |
Appl Environ Microbiol |
10.1128/AEM.02239-06 |
2007 |
* |
| Phylogeny |
Actinomadura rudentiformis sp. nov., isolated from soil. |
le Roes M, Meyers PR |
Int J Syst Evol Microbiol |
10.1099/ijs.0.64438-0 |
2007 |
* |
| Pathogenicity |
[Molecular analysis of vancomycin-resistant enterococci isolated from clinical samples]. |
Kilic A, Senses Z, Aydogan H, Basustaoglu A |
Mikrobiyol Bul |
|
2006 |
* |
| Phenotype |
Case report vancomycin -resistant Enterococcus faecium VanA phenotype: first documented isolation in India. |
Mohanty S, Dhawan B, Gadepalli RS, Lodha R, Kapil A |
Southeast Asian J Trop Med Public Health |
|
2006 |
* |
| Pathogenicity |
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. |
Vouillamoz J, Moreillon P, Giddey M, Entenza JM |
J Antimicrob Chemother |
10.1093/jac/dkl406 |
2006 |
* |
| Pathogenicity |
Sources and pathways of spread of vancomycin-resistant enterococci in hemato-oncological patients. |
Vagnerova I, Sauer P, Kolar M, Slepickova S, Hubacek J, Faber E, Raida L, Papajik T |
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |
10.5507/bp.2006.017 |
2006 |
* |
| Pathogenicity |
Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. |
Kolar M, Pantucek R, Vagnerova I, Sauer P, Kesselova M, Cekanova L, Koukalova D, Doskar J, Ruzickova V |
New Microbiol |
|
2006 |
* |
| Transcriptome |
Sequence analysis of Enterococcus faecium strain 10/96A (VanD4), the original vancomycin-resistant E. faecium strain in Brazil. |
Camargo IL, Dalla Costa LM, Woodford N, Gilmore MS, Darini AL |
J Clin Microbiol |
10.1128/JCM.00509-06 |
2006 |
* |
| Phylogeny |
Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech Republic. |
Kolar M, Pantucek R, Vagnerova I, Kesselova M, Sauer P, Matouskova I, Doskar J, Koukalova D, Hejnar P |
Clin Microbiol Infect |
10.1111/j.1469-0691.2006.01365.x |
2006 |
* |
| Pathogenicity |
Clinical glycopeptide-resistant enterococci isolated from patients after solid organ transplantation. |
Sawicka-Grzelak A, Rokosz A, Przybylski M, Kawecki D, Krawczyk E, Rowinski W, Durlik M, Paczek L, Luczak M |
Transplant Proc |
10.1016/j.transproceed.2005.11.095 |
2006 |
* |
| Pathogenicity |
Comparative study of vanA gene transfer from Enterococcus faecium to Enterococcus faecalis and to Enterococcus faecium in the intestine of mice. |
Bourgeois-Nicolaos N, Moubareck C, Mangeney N, Butel MJ, Doucet-Populaire F |
FEMS Microbiol Lett |
10.1111/j.1574-6968.2005.00004.x |
2006 |
* |
| Phylogeny |
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. |
Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, Borgmann S, Schulte B, Jonas D, Serr A, Fahr AM, Eigner U, Witte W |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-005-0056-0 |
2005 |
* |
| Pathogenicity |
High prevalence of VanA-type vancomycin-resistant Enterococci in Austrian poultry. |
Eisner A, Feierl G, Gorkiewicz G, Dieber F, Kessler HH, Marth E, Kofer J |
Appl Environ Microbiol |
10.1128/AEM.71.10.6407-6409.2005 |
2005 |
* |
| Pathogenicity |
[Pathogenic characters of infected bacteria after liver transplantation]. |
Zhou JD, Zhu SH, Chen Y, Nie XM, Peng HY, Cheng K |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
|
2005 |
* |
| Pathogenicity |
Occurrence of vancomycin-resistant enterococci in humans and animals in the Czech Republic between 2002 and 2004. |
Kolar M, Pantucek R, Bardon J, Cekanova L, Kesselova M, Sauer P, Vagnerova I, Koukalova D |
J Med Microbiol |
10.1099/jmm.0.45824-0 |
2005 |
* |
| Pathogenicity |
Community-acquired vancomycin-resistant Enterococcus faecium: a case report from Malaysia. |
Raja NS, Karunakaran R, Ngeow YF, Awang R |
J Med Microbiol |
10.1099/jmm.0.46169-0 |
2005 |
* |
| Genetics |
First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. |
Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P |
J Clin Microbiol |
10.1128/JCM.43.8.3642-3649.2005 |
2005 |
* |
| Pathogenicity |
[Prevalence of vancomycin-resistant enterococci in hospital and community environment.]. |
Kolar M, Pantucek R, Vagnerova I, Cekanova L, Kesselova M, Sauer P, Koukalova D, Kolar V, Ruzi kova M, Dosar J |
Klin Mikrobiol Infekc Lek |
|
2005 |
* |
| Pathogenicity |
Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea. |
Ko KS, Baek JY, Lee JY, Oh WS, Peck KR, Lee N, Lee WG, Lee K, Song JH |
J Clin Microbiol |
10.1128/JCM.43.5.2303-2306.2005 |
2005 |
* |
| Pathogenicity |
Occurrence of insertion sequences within the genomes and Tn1546-like elements of glycopeptide-resistant enterococci isolated in Brazil, and identification of a novel element, ISEfa5. |
Camargo IL, Zanella RC, Brandileone MC, Pignatari AC, Goldman GH, Woodford N, Darini AL |
Int J Med Microbiol |
10.1016/j.ijmm.2004.11.003 |
2005 |
* |
| Pathogenicity |
Identification of an unusual VanA element in glycopeptide-resistant Enterococcus faecium in Brazil following international transfer of a bone marrow transplant patient. |
Camargo IL, Del Peloso PF, Da Costa Leite CF, Goldman GH, Darini AL |
Can J Microbiol |
10.1139/w04-054 |
2004 |
* |
| Pathogenicity |
Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods. |
Kobayashi I, Muraoka H, Iyoda T, Nishida M, Hasegawa M, Yamaguchi K |
J Med Microbiol |
10.1099/jmm.0.45765-0 |
2004 |
* |
| Pathogenicity |
[The frequency of resistance to antibiotics of most frequently isolated bacteria from blood cultures during the period 1997-2002]. |
Mirovic V, Tomanovic B, Konstantinovic S |
Vojnosanit Pregl |
10.2298/vsp0404391m |
2004 |
* |
| Pathogenicity |
The emergence of glycopeptide-resistant Enterococcus faecium in a university hospital in southwestern Greece. |
Kolonitsiou F, Mani V, Parikou H, Trakala M, Dimitracopoulos G, Spiliopoulou I |
Chemotherapy |
10.1159/000081945 |
2004 |
* |
| Pathogenicity |
Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation. |
Christidou A, Gikas A, Scoulica E, Pediaditis J, Roumbelaki M, Georgiladakis A, Tselentis Y |
Clin Microbiol Infect |
10.1111/j.1469-0691.2004.00992.x |
2004 |
* |
| Pathogenicity |
Two episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unit. |
Borgmann S, Niklas DM, Klare I, Zabel LT, Buchenau P, Autenrieth IB, Heeg P |
Int J Hyg Environ Health |
10.1078/1438-4639-00304 |
2004 |
* |
| Pathogenicity |
Clonal dissemination of VanA-type glycopeptide-resistant Enterococcus faecalis between hospitals of two cities located 100 km apart. |
Moretti ML, Bratfich OJ, Stucchi RB, Levi C, Levin AS, Duboc GM, Vormittag E, Blum-Menezes D |
Braz J Med Biol Res |
10.1590/s0100-879x2004000900008 |
2004 |
* |
| Enzymology |
Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. |
Huh JY, Lee WG, Lee K, Shin WS, Yoo JH |
J Clin Microbiol |
10.1128/JCM.42.5.1897-1902.2004 |
2004 |
* |
| Phylogeny |
Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material. |
Novicki TJ, Schapiro JM, Ulness BK, Sebeste A, Busse-Johnston L, Swanson KM, Swanzy SR, Leisenring W, Limaye AP |
J Clin Microbiol |
10.1128/JCM.42.4.1637-1640.2004 |
2004 |
* |
| Pathogenicity |
Highly conjugative pMG1-like plasmids carrying Tn1546-like transposons that encode vancomycin resistance in Enterococcus faecium. |
Tomita H, Tanimoto K, Hayakawa S, Morinaga K, Ezaki K, Oshima H, Ike Y |
J Bacteriol |
10.1128/JB.185.23.7024-7028.2003 |
2003 |
* |
| Pathogenicity |
Occurrence and spread of antibiotic resistances in Enterococcus faecium. |
Klare I, Konstabel C, Badstubner D, Werner G, Witte W |
Int J Food Microbiol |
10.1016/s0168-1605(03)00190-9 |
2003 |
* |
| Pathogenicity |
Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). |
Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ |
J Antimicrob Chemother |
10.1093/jac/dkg352 |
2003 |
* |
| Genetics |
Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. |
Campanile F, Bartoloni A, Bartalesi F, Borbone S, Mangani V, Mantella A, Nicoletti G, Paradisi F, Russo G, Strohmeyer M, Stefani S |
Microb Drug Resist |
10.1089/107662903765826796 |
2003 |
* |
| Pathogenicity |
European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. |
Goossens H, Jabes D, Rossi R, Lammens C, Privitera G, Courvalin P |
J Antimicrob Chemother |
10.1093/jac/dkg271 |
2003 |
* |
| Pathogenicity |
Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). |
Mutnick AH, Biedenbach DJ, Jones RN |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(03)00012-9 |
2003 |
* |
| Pathogenicity |
Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue. |
Ahrendt KA, Olsen JA, Wakao M, Trias J, Ellman JA |
Bioorg Med Chem Lett |
10.1016/s0960-894x(03)00243-9 |
2003 |
* |
| Pathogenicity |
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. |
Shin JW, Yong D, Kim MS, Chang KH, Lee K, Kim JM, Chong Y |
J Infect Chemother |
10.1007/s10156-002-0215-5 |
2003 |
* |
| Pathogenicity |
[Detection of vancomycin-resistant Enterococcus faecium: 2 years' experience in a high complexity hospital ]. |
Lopreto CR, Viegas Caetano JA, Padlog R, Sorgentini M, Bardi C, Silvestri C |
Rev Argent Microbiol |
|
2002 |
* |
| Pathogenicity |
Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center. |
Rodriguez JL, Vazquez GJ, Bermudez M, De Orbeta J, Garcia Y, Rivera Y, Robledo IE |
P R Health Sci J |
|
2002 |
* |
| Pathogenicity |
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model. |
Nannini EC, Pai SR, Singh KV, Murray BE |
Antimicrob Agents Chemother |
10.1128/AAC.47.2.529-532.2003 |
2003 |
* |
| Pathogenicity |
A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand. |
Manson JM, Keis S, Smith JM, Cook GM |
Antimicrob Agents Chemother |
10.1128/AAC.47.1.204-210.2003 |
2003 |
* |
| Pathogenicity |
[Antibiotic resistance in hospital strains of Enterococcus faecalis and Enterococcus faecium]. |
Mirovic V |
Vojnosanit Pregl |
10.2298/vsp0205499m |
2002 |
* |
| Pathogenicity |
Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. |
Johnsen PJ, Simonsen GS, Olsvik O, Midtvedt T, Sundsfjord A |
Microb Drug Resist |
10.1089/107662902760326869 |
2002 |
* |
| Enzymology |
First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. |
Colak D, Naas T, Gunseren F, Fortineau N, Ogunc D, Gultekin M, Nordmann P |
J Antimicrob Chemother |
10.1093/jac/dkf134 |
2002 |
* |
| Cultivation |
Possible connection between a widely disseminated conjugative gentamicin resistance (pMG1-like) plasmid and the emergence of vancomycin resistance in Enterococcus faecium. |
Tomita H, Pierson C, Lim SK, Clewell DB, Ike Y |
J Clin Microbiol |
10.1128/JCM.40.9.3326-3333.2002 |
2002 |
* |
| Enzymology |
First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. |
Panesso D, Ospina S, Robledo J, Vela MC, Pena J, Hernandez O, Reyes J, Arias CA |
Emerg Infect Dis |
10.3201/eid0809.010435 |
2002 |
* |
| Pathogenicity |
The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use. |
Kolar M, Vagnerova I, Latal T, Urbanek K, Typovska H, Hubacek J, Papajik T, Raida L, Faber E |
New Microbiol |
|
2002 |
* |
| Pathogenicity |
Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci. |
Shigei J, Tan G, Shiao A, de la Maza LM, Peterson EM |
Am J Clin Pathol |
10.1309/TWY5-04QE-9KV0-52MT |
2002 |
* |
| Pathogenicity |
Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. |
Woodford N |
Microb Drug Resist |
10.1089/10766290152652774 |
2001 |
* |
| Metabolism |
The VanY(D) DD-carboxypeptidase of Enterococcus faecium BM4339 is a penicillin-binding protein. |
Reynolds PE, Ambur OH, Casadewall B, Courvalin P |
Microbiology (Reading) |
10.1099/00221287-147-9-2571 |
2001 |
* |
| Genetics |
Characterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. |
Demertzi E, Palepou MI, Kaufmann ME, Avlamis A, Woodford N |
J Med Microbiol |
10.1099/0022-1317-50-8-682 |
2001 |
* |
| Pathogenicity |
Recovery from a single blood culture of two enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. |
Biavasco F, Paladini C, Vignaroli C, Foglia G, Manso E, Varaldo PE |
Eur J Clin Microbiol Infect Dis |
10.1007/pl00011270 |
2001 |
* |
| Pathogenicity |
Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model. |
Rupp ME, Fey PD, Longo GM |
J Antimicrob Chemother |
10.1093/jac/47.5.705 |
2001 |
* |
| Pathogenicity |
In-vitro activity of fosfomycin against vancomycin-resistant enterococci. |
Allerberger F, Klare I |
J Antimicrob Chemother |
10.1093/jac/43.2.211 |
1999 |
* |
| Phylogeny |
Vancomycin-resistant Enterococcus faecium strain carrying the vanB2 gene variant in a Polish hospital. |
Kawalec M, Gniadkowski M, Zielinska U, Klos W, Hryniewicz W |
J Clin Microbiol |
10.1128/JCM.39.2.811-815.2001 |
2001 |
* |
| Pathogenicity |
Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiologic features. |
Carretto E, Barbarini D, Locatelli F, Giraldi E, Pellegrini N, Perversi L, Grossi P, Marone P, Bonetti F |
Haematologica |
|
2000 |
* |
| Pathogenicity |
Impact of flavophospholipol and vancomycin on conjugational transfer of vancomycin resistance plasmids. |
Riedl S, Ohlsen K, Werner G, Witte W, Hacker J |
Antimicrob Agents Chemother |
10.1128/AAC.44.11.3189-3192.2000 |
2000 |
* |
| Enzymology |
Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains. |
Kawalec M, Gniadkowski M, Hryniewicz W |
J Clin Microbiol |
10.1128/JCM.38.9.3317-3322.2000 |
2000 |
* |
| Enzymology |
Genotypic characterisation of endemic VanA Enterococcus faecium strains isolated in a paediatric hospital. |
Barnaud G, Bingen E |
J Med Microbiol |
10.1099/0022-1317-49-9-793 |
2000 |
* |
| Pathogenicity |
Problems and perils of vancomycin resistant enterococci. |
Murray BE |
Braz J Infect Dis |
|
2000 |
* |
| Pathogenicity |
PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium. |
Donabedian S, Hershberger E, Thal LA, Chow JW, Clewell DB, Robinson-Dunn B, Zervos MJ |
J Clin Microbiol |
10.1128/JCM.38.8.2885-2888.2000 |
2000 |
* |
| Pathogenicity |
The molecular basis of vancomycin resistance in clinically relevant Enterococci: crystal structure of D-alanyl-D-lactate ligase (VanA). |
Roper DI, Huyton T, Vagin A, Dodson G |
Proc Natl Acad Sci U S A |
10.1073/pnas.150116497 |
2000 |
* |
| Pathogenicity |
Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. |
Simonsen GS, Myhre MR, Dahl KH, Olsvik O, Sundsfjord A |
Microb Drug Resist |
10.1089/mdr.2000.6.49 |
2000 |
* |
| Pathogenicity |
Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. |
Nelson RR, McGregor KF, Brown AR, Amyes SG, Young H |
J Clin Microbiol |
10.1128/JCM.38.6.2112-2116.2000 |
2000 |
* |
| Phylogeny |
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. |
Garcia-Garrote F, Cercenado E, Bouza E |
J Clin Microbiol |
10.1128/JCM.38.6.2108-2111.2000 |
2000 |
* |
| Genetics |
Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium. |
Darini AL, Palepou MF, Woodford N |
Antimicrob Agents Chemother |
10.1128/AAC.44.5.1362-1364.2000 |
2000 |
* |
| Pathogenicity |
Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. |
Nourse C, Byrne C, Murphy H, Kaufmann ME, Clarke A, Butler K |
Epidemiol Infect |
10.1017/s095026889900326x |
2000 |
* |
| Pathogenicity |
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. |
Ostrowsky BE, Clark NC, Thauvin-Eliopoulos C, Venkataraman L, Samore MH, Tenover FC, Eliopoulos GM, Moellering RC Jr, Gold HS |
J Infect Dis |
10.1086/315030 |
1999 |
* |
| Phenotype |
First confirmed case of a vancomycin-resistant Enterococcus faecium with vanA phenotype from Brazil: isolation from a meningitis case in Sao Paulo. |
Zanella RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SC, Vieira VS, Brandileone MC |
Microb Drug Resist |
10.1089/mdr.1999.5.159 |
1999 |
* |
| Enzymology |
Crystallization and preliminary X-ray characterization of VanA from Enterococcus faecium BM4147: towards the molecular basis of bacterial resistance to the glycopeptide antibiotic vancomycin. |
Huyton T, Roper DI |
Acta Crystallogr D Biol Crystallogr |
10.1107/s0907444999007155 |
1999 |
* |
| Genetics |
Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. |
Casadewall B, Courvalin P |
J Bacteriol |
10.1128/JB.181.12.3644-3648.1999 |
1999 |
* |
| Pathogenicity |
Nucleotide sequence of IS1542, an insertion sequence identified within VanA glycopeptide resistance elements of enterococci. |
Darini AL, Palepou MF, Woodford N |
FEMS Microbiol Lett |
10.1111/j.1574-6968.1999.tb13523.x |
1999 |
* |
| Pathogenicity |
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. |
Simonsen GS, Andersen BM, Digranes A, Harthug S, Jacobsen T, Lingaas E, Natas OB, Olsvik O, Ringertz SH, Skulberg A, Syversen G, Sundsfjord A |
Scand J Infect Dis |
10.1080/00365549850161449 |
1998 |
* |
| Phylogeny |
Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland. |
Samet A, Bronk M, Hellmann A, Kur J |
J Hosp Infect |
10.1016/s0195-6701(99)90051-8 |
1999 |
* |
| Pathogenicity |
Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. |
Simonsen GS, Haaheim H, Dahl KH, Kruse H, Lovseth A, Olsvik O, Sundsfjord A |
Microb Drug Resist |
10.1089/mdr.1998.4.313 |
1998 |
* |
| Enzymology |
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. |
Kim WJ, Weinstein RA, Hayden MK |
J Infect Dis |
10.1086/314564 |
1999 |
* |
| Enzymology |
Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. |
Brown AR, Amyes SG, Paton R, Plant WD, Stevenson GM, Winney RJ, Miles RS |
J Hosp Infect |
10.1016/s0195-6701(98)90090-1 |
1998 |
* |
| Pathogenicity |
Glycopeptide-resistant enterococci: a decade of experience. |
Woodford N |
J Med Microbiol |
10.1099/00222615-47-10-849 |
1998 |
* |
| Pathogenicity |
European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. |
Felmingham D, Brown DF, Soussy CJ |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(98)00053-4 |
1998 |
* |
| Pathogenicity |
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. |
Bell JM, Paton JC, Turnidge J |
J Clin Microbiol |
10.1128/JCM.36.8.2187-2190.1998 |
1998 |
* |
| Pathogenicity |
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. |
Eliopoulos GM, Wennersten CB, Gold HS, Schulin T, Souli M, Farris MG, Cerwinka S, Nadler HL, Dowzicky M, Talbot GH, Moellering RC Jr |
Antimicrob Agents Chemother |
10.1128/AAC.42.5.1088 |
1998 |
* |
| Metabolism |
Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. |
Woodford N, Adebiyi AM, Palepou MF, Cookson BD |
Antimicrob Agents Chemother |
10.1128/AAC.42.3.502 |
1998 |
* |
| Enzymology |
Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. |
Nourse C, Murphy H, Byrne C, O'Meara A, Breatnach F, Kaufmann M, Clarke A, Butler K |
Eur J Pediatr |
10.1007/s004310050760 |
1998 |
* |
| Genetics |
Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak. |
Woodford N, Chadwick PR, Morrison D, Cookson BD |
J Clin Microbiol |
10.1128/jcm.35.11.2966-2968.1997 |
1997 |
* |
| Genetics |
VanD-type glycopeptide-resistant Enterococcus faecium BM4339. |
Perichon B, Reynolds P, Courvalin P |
Antimicrob Agents Chemother |
10.1128/AAC.41.9.2016 |
1997 |
* |
| Genetics |
Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. |
MacKinnon MG, Drebot MA, Tyrrell GJ |
Antimicrob Agents Chemother |
10.1128/AAC.41.8.1805 |
1997 |
* |
| Pathogenicity |
Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci. |
Sahm DF, Free L, Smith C, Eveland M, Mundy LM |
J Clin Microbiol |
10.1128/jcm.35.8.2026-2030.1997 |
1997 |
* |
| Phylogeny |
Comparison of agar-based media for primary isolation of glycopeptide-resistant enterococci. |
Chadwick PR, Brown DF, Wilcox MH, Collyns TA, Walpole E, Dillon J, Smith R, Gopal Rao G, Oppenheim BA |
Clin Microbiol Infect |
10.1111/j.1469-0691.1997.tb00308.x |
1997 |
* |
| Enzymology |
Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. |
Torell E, Fredlund H, Tornquist E, Myhre EB, Sjoberg L, Sundsfjord A |
Scand J Infect Dis |
10.3109/00365549709019039 |
1997 |
* |
| Genetics |
The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. |
Arthur M, Depardieu F, Gerbaud G, Galimand M, Leclercq R, Courvalin P |
J Bacteriol |
10.1128/jb.179.1.97-106.1997 |
1997 |
* |
| Pathogenicity |
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. |
Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH |
J Hosp Infect |
10.1016/s0195-6701(96)90063-8 |
1996 |
* |
| Pathogenicity |
Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. |
Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H |
Antimicrob Agents Chemother |
10.1128/AAC.40.8.1938 |
1996 |
* |
| Metabolism |
Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. |
Arthur M, Depardieu F, Reynolds P, Courvalin P |
Mol Microbiol |
10.1046/j.1365-2958.1996.00617.x |
1996 |
* |
| Pathogenicity |
Vancomycin-resistant enterococci. |
Gin AS, Zhanel GG |
Ann Pharmacother |
10.1177/106002809603000610 |
1996 |
* |
| Genetics |
Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid. |
Heaton MP, Discotto LF, Pucci MJ, Handwerger S |
Gene |
10.1016/0378-1119(96)00022-4 |
1996 |
* |
| Pathogenicity |
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. |
Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ |
Antimicrob Agents Chemother |
10.1128/AAC.40.4.839 |
1996 |
* |
| Metabolism |
Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. |
Ellsworth BA, Tom NJ, Bartlett PA |
Chem Biol |
10.1016/s1074-5521(96)90082-4 |
1996 |
* |
| Pathogenicity |
In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species. |
Biavasco F, Giovanetti E, Miele A, Vignaroli C, Facinelli B, Varaldo PE |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01586185 |
1996 |
* |
| Pathogenicity |
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. |
Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann G, Hakenbeck R, Antanassova V, Witte W |
Microb Drug Resist |
10.1089/mdr.1995.1.265 |
1995 |
* |
| Pathogenicity |
Conjugative mobilization of a vancomycin resistance plasmid by a putative Enterococcus faecium sex pheromone response plasmid. |
Heaton MP, Handwerger S |
Microb Drug Resist |
10.1089/mdr.1995.1.177 |
1995 |
* |
| Pathogenicity |
In vitro activity of the semisynthetic glycopeptide amide MDL 63,246. |
Kenny MT, Brackman MA, Dulworth JK |
Antimicrob Agents Chemother |
10.1128/AAC.39.7.1589 |
1995 |
* |
| Genetics |
Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. |
Handwerger S, Skoble J, Discotto LF, Pucci MJ |
Antimicrob Agents Chemother |
10.1128/AAC.39.2.362 |
1995 |
* |
| Enzymology |
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. |
Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN |
J Clin Microbiol |
10.1128/jcm.32.11.2840-2842.1994 |
1994 |
* |
| Pathogenicity |
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. |
Bates J, Jordens JZ, Griffiths DT |
J Antimicrob Chemother |
10.1093/jac/34.4.507 |
1994 |
* |
| Metabolism |
Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. |
Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P |
Mol Microbiol |
10.1111/j.1365-2958.1994.tb00497.x |
1994 |
* |
| Genetics |
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. |
Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F |
J Antimicrob Chemother |
10.1093/jac/33.3.553 |
1994 |
* |
| Enzymology |
Characterization of glycopeptide-resistant enterococci from U.S. hospitals. |
Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC |
Antimicrob Agents Chemother |
10.1128/AAC.37.11.2311 |
1993 |
* |
| Pathogenicity |
Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. |
Green M, Binczewski B, Pasculle AW, Edmund M, Barbadora K, Kusne S, Shlaes DM |
Antimicrob Agents Chemother |
10.1128/AAC.37.6.1238 |
1993 |
* |
| Enzymology |
In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. |
Hayden MK, Trenholme GM, Schultz JE, Sahm DF |
J Infect Dis |
10.1093/infdis/167.5.1224 |
1993 |
* |
| Pathogenicity |
Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. |
Fraimow HS, Venuti E |
Antimicrob Agents Chemother |
10.1128/AAC.36.7.1563 |
1992 |
* |
| Pathogenicity |
Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. |
Wright GD, Molinas C, Arthur M, Courvalin P, Walsh CT |
Antimicrob Agents Chemother |
10.1128/AAC.36.7.1514 |
1992 |
* |
| Enzymology |
The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. |
Arthur M, Molinas C, Courvalin P |
J Bacteriol |
10.1128/jb.174.8.2582-2591.1992 |
1992 |
* |
| Metabolism |
Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. |
Arthur M, Molinas C, Bugg TD, Wright GD, Walsh CT, Courvalin P |
Antimicrob Agents Chemother |
10.1128/AAC.36.4.867 |
1992 |
* |
| Pathogenicity |
Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. |
Handwerger S, Perlman DC, Altarac D, McAuliffe V |
Clin Infect Dis |
10.1093/clinids/14.3.655 |
1992 |
* |
| Enzymology |
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. |
Bugg TD, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT |
Biochemistry |
10.1021/bi00107a007 |
1991 |
* |
| Enzymology |
Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. |
Bugg TD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT |
Biochemistry |
10.1021/bi00222a002 |
1991 |
* |
| Pathogenicity |
Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium. |
Gargvanshi S, Gutheil WG |
Microbiol Spectr |
10.1128/spectrum.01412-22 |
2022 |
* |
|
Nigella sativa oil extract: A natural novel specific conjugal transfer inhibitor of vancomycin resistance from vanA/B-resistant Enterococcus faecium to Staphylococcus aureus. |
Ahmad AAM, Gharib AA, Elshorbgy I, Elewasy OA, Elmowalid GA |
J Appl Microbiol |
10.1111/jam.15567 |
2022 |
* |
|
High-Resolution Genotyping Unveils Identical Ampicillin-Resistant Enterococcus faecium Strains in Different Sources and Countries: A One Health Approach. |
Freitas AR, Tedim AP, Almeida-Santos AC, Duarte B, Elghaieb H, Abbassi MS, Hassen A, Novais C, Peixe L |
Microorganisms |
10.3390/microorganisms10030632 |
2022 |
* |
|
Rapid and Reproducible MALDI-TOF-Based Method for the Detection of Vancomycin-Resistant Enterococcus faecium Using Classifying Algorithms. |
Candela A, Arroyo MJ, Sanchez-Molleda A, Mendez G, Quiroga L, Ruiz A, Cercenado E, Marin M, Munoz P, Mancera L, Rodriguez-Temporal D, Rodriguez-Sanchez B |
Diagnostics (Basel) |
10.3390/diagnostics12020328 |
2022 |
* |
|
Increasing Trend of Vancomycin-resistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-year Prospective Study. |
Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS |
Indian J Crit Care Med |
10.5005/jp-journals-10071-23916 |
2021 |
* |
|
Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients. |
Hricova K, Stosova T, Kucova P, Fiserova K, Bardon J, Kolar M |
Antibiotics (Basel) |
10.3390/antibiotics9110785 |
2020 |
* |
|
VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells. |
Vimberg V, Zieglerova L, Buriankova K, Branny P, Balikova Novotna G |
Front Microbiol |
10.3389/fmicb.2020.00566 |
2020 |
* |
|
Impact on Public Health of the Spread of High-Level Resistance to Gentamicin and Vancomycin in Enterococci. |
Sparo M, Delpech G, Garcia Allende N |
Front Microbiol |
10.3389/fmicb.2018.03073 |
2018 |
* |
|
Genetic characteristics of VanA-type vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in Cuba. |
Quinones D, Aung MS, Sousa Martins JP, Urushibara N, Kobayashi N |
New Microbes New Infect |
10.1016/j.nmni.2017.12.001 |
2017 |
* |
|
Investigation of vancomycin resistant Enterococcus faecium outbreak in neonatal intensive care unit. |
Cilo BD, Agca H, Efe K, Sinirtas M, Celebi S, Ozkan H, Koksal N, Hacimustafaoglu M, Ozakin C |
Int J Clin Exp Med |
|
2014 |
* |
|
Neonatal septicaemia caused by vancomycin resistant enterococcus faecium-a case report. |
Gb S, T N, Dr P, Tr H, R K |
J Clin Diagn Res |
10.7860/JCDR/2014/10284.5220 |
2014 |
* |
|
High frequency of vancomycin-resistant enterococcus faecalis in an Iranian referral children medical hospital. |
Pourakbari B, Aghdam MK, Mahmoudi S, Ashtiani MT, Sabouni F, Movahedi Z, Alyari AE, Sadeghi RH, Mamishi S |
Maedica (Bucur) |
|
2012 |
* |
|
Proteomic characterization of vanA-containing Enterococcus recovered from Seagulls at the Berlengas Natural Reserve, W Portugal. |
Radhouani H, Poeta P, Pinto L, Miranda J, Coelho C, Carvalho C, Rodrigues J, Lopez M, Torres C, Vitorino R, Domingues P, Igrejas G |
Proteome Sci |
10.1186/1477-5956-8-48 |
2010 |
* |
|
Identification of enterococci and determination of their glycopeptide resistance in German and Austrian clinical microbiology laboratories. |
Klare I, Badstubner D, Konstabel C, Witte W |
Clin Microbiol Infect |
10.1111/j.1469-0691.1999.tb00431.x |
1999 |
* |
|
Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. |
Boisivon A, Thibault M, Leclercq R |
Clin Microbiol Infect |
10.1111/j.1469-0691.1997.tb00594.x |
1997 |
* |
|
Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. |
Moulin F, Dumontier S, Saulnier P, Chachaty E, Loubeyre C, Brugieres L, Andremont A |
Clin Microbiol Infect |
10.1016/s1198-743x(14)65142-9 |
1996 |
* |
Name and taxonomic classification
Morphology
Culture and growth conditions
Physiology and metabolism
Isolation, sampling and environmental information
Safety information
External links
References
